Substance Use While Pregnant and Breastfeeding
Research shows that use of tobacco, alcohol, or illicit drugs or abuse of prescription drugs by pregnant women can have severe health consequences for infants. This is because many substances pass easily through the placenta, so substances that a pregnant woman takes also, to some degree, reach the baby (Neonatal abstinence syndrome, 2014). Recent research shows that smoking tobacco or marijuana, taking prescription pain relievers, or using illegal drugs during pregnancy is associated with double or even triple the risk of stillbirth (Tobacco, drug use in pregnancy, 2013).
Risks of Stillbirth from Substance Use in Pregnancy
- Tobacco use—1.8 to 2.8 times greater risk of stillbirth, with the highest risk found among the heaviest smokers
- Marijuana use—2.3 times greater risk of stillbirth
- Evidence of any stimulant, marijuana, or prescription pain reliever use—2.2 times greater risk of stillbirth
- Passive exposure to tobacco—2.1 times greater risk of stillbirth
Source: Tobacco, drug use in pregnancy, 2013
Regular drug use can produce dependence in the newborn, and the baby may go through withdrawal upon birth. Most research in this area has focused on the effects of opioid misuse (prescription pain relievers or heroin). However, more recent data has shown that use of alcohol, barbiturates, benzodiazepines, and caffeine during pregnancy may also cause the infant to show withdrawal symptoms at birth (Hudak et al., 2012). The type and severity of an infant's withdrawal symptoms depend on the drug(s) used, how long and how often the birth mother used, how her body breaks the drug down, and whether the infant was born full term or prematurely (Neonatal abstinence syndrome, 2014).
Symptoms of drug withdrawal in a newborn can develop immediately or up to 14 days after birth and can include (Hudak, 2012):
- blotchy skin coloring
- excessive or high-pitched crying
- abnormal sucking reflex
- hyperactive reflexes
- increased muscle tone
- poor feeding
- rapid breathing
- increased heart rate
- sleep problems
- slow weight gain
- stuffy nose and sneezing
Effects of using some drugs could be long-term and possibly fatal to the baby (Neonatal abstinence syndrome, 2014):
- low birth weight
- birth defects
- small head circumference
- premature birth
- sudden infant death syndrome (SIDS)
More research needs to be done on how marijuana use during pregnancy could impact the health and development of infants, given changing policies about access to marijuana, as well as significant increases over the last decade in the number of pregnant women seeking substance use disorder treatment for marijuana use (Martin et al., 2015).
There is no human research connecting marijuana use to the chance of miscarriage (Kline et al., 1991; Wilcox et al., 1990), although animal studies indicate that the risk for miscarriage increases if marijuana is used early in pregnancy (Asch & Smith, 1986). Some associations have been found between marijuana use during pregnancy and future developmental and hyperactivity disorders in children (Campolongo et al., 2011; Fried et al., 1992; Goldschmidt et al., 2000; Fried & Smith, 2001). Evidence is mixed as to whether marijuana use by pregnant women is associated with low birth rate (Janisse et al., 2014; Hayatbakhsh et al., 2012; Shiono et al., 1995; Mark et al., 2015; Schempf & Strobino, 2008) or premature birth (Mark et al., 2015), although long-term use may elevate these risks (Shiono et al., 1995). Given the potential of marijuana to negatively impact the developing brain, the American College of Obstetricians and Gynecologists recommends that obstetrician-gynecologists counsel women against using marijuana while trying to get pregnant, during pregnancy, and while they are breastfeeding (ACOG, 2015).
Some women report using marijuana to treat severe nausea associated with their pregnancy (Roberson et al., 2014; Westfall et al., 2006); however, there is no research confirming that this is a safe practice, and it is generally not recommended. Women considering using medical marijuana while pregnant should not do so without checking with their health care providers. Animal studies have shown that moderate concentrations of delta-9-tetrahydrocannabinol (or THC, the main psychoactive ingredient in marijuana), when administered to mothers while pregnant or nursing, could have long-lasting effects on the child, including increasing stress responsivity and abnormal patterns of social interactions (Trezza et al., 2008). Animal studies also show learning deficits in prenatally exposed individuals (Antonelli et al., 2005; Mereu et al., 2003).
Human research has shown that some babies born to women who used marijuana during their pregnancies display altered responses to visual stimuli, increased trembling, and a high-pitched cry (Fried & Makin, 1987), which could indicate problems with neurological development (de Moraes et al., 2008). In school, marijuana-exposed children are more likely to show gaps in problem-solving skills, memory (Richardson et al., 2002), and the ability to remain attentive (Goldschmidt et al., 2000). More research is needed, however, to disentangle marijuana-specific effects from those of other environmental factors that could be associated with a mother's marijuana use, such as an impoverished home environment or the mother's use of other drugs (Schempf & Strobino, 2008). Prenatal marijuana exposure is also associated with an increased likelihood of a person using marijuana as a young adult, even when other factors that influence drug use are considered (Sonon et al., 2015). More information on marijuana use during pregnancy can be found in NIDA's Marijuana Research Report.
Very little is known about marijuana use and breastfeeding. One study suggests that moderate amounts of THC find their way into breast milk when a nursing mother uses marijuana (Perez-Reyes & Wall, 1982). Some evidence shows that exposure to THC through breast milk in the first month of life could result in decreased motor development at 1 year of age (Astley & Little, 1990). There have been no studies to determine if exposure to THC during nursing is linked to effects later in the child's life. With regular use, THC can accumulate in human breast milk to high concentrations (Perez-Reyes & Wall, 1982). Because a baby's brain is still forming, THC consumed in breast milk could affect brain development. Given all these uncertainties, nursing mothers are discouraged from using marijuana (ACOG, 2015; Djulus et al., 2005). New mothers using medical marijuana should be vigilant about coordinating care between the doctor recommending their marijuana use and the pediatrician caring for their baby.
Stimulants (Cocaine and Methamphetamine)
Some may recall news items about "crack babies," a term coined in the 1980s to describe babies born to mothers who smoked cocaine while pregnant. These babies were initially predicted to suffer from severe, irreversible cognitive and behavioral consequences, including reduced intelligence and social skills. These purported effects turned out to be somewhat exaggerated. However, it is not completely known how a pregnant woman's cocaine use affects her child, since cocaine-using women are more likely to also use other drugs such as alcohol, to have poor nutrition, or to not seek prenatal care. All of these factors can affect a developing fetus, making it difficult to isolate the effects of cocaine (Cain et al., 2013).
Research does show, however, that pregnant women who use cocaine are at higher risk for maternal migraines and seizures, premature membrane rupture, and placental abruption (separation of the placental lining from the uterus) (Wendell, 2013). Pregnancy is accompanied by normal cardiovascular changes, and cocaine abuse exacerbates these changes—sometimes leading to serious problems with high blood pressure (hypertensive crises), spontaneous miscarriage, preterm labor, and difficult delivery (Cain et al., 2013). Babies born to mothers who use cocaine during pregnancy may also have low birth weight and smaller head circumferences, and are shorter in length than babies born to mothers who do not use cocaine. They also show symptoms of irritability, hyperactivity, tremors, high-pitched cry, and excessive sucking at birth (Bauer et al., 2005). These symptoms may be due to the effects of cocaine itself, rather than withdrawal, since cocaine and its metabolites are still present in the baby's body up to 5 to 7 days after delivery (Chasnoff et al., 1986; Eyler et al., 2001).
Pregnant women who use methamphetamine have a greater risk of preeclampsia (high blood pressure and possible organ damage) (Gorman et al., 2014), premature delivery, and placental abruption. Their babies are more likely to be smaller and to have low birth weight (Smith et al., 2006). In a large, longitudinal study of children prenatally exposed to methamphetamine, exposed children had increased emotional reactivity and anxiety/depression, were more withdrawn, had problems with attention, and showed cognitive problems that could lead to poorer academic outcomes (Diaz et al., 2014; LaGasse et al., 2012).
MDMA (Ecstasy, Molly)
What little research exists on the effects of MDMA use in pregnancy suggests that prenatal MDMA exposure may cause learning, memory (Schaefer et al., 2013), and motor problems in the baby (Singer et al., 2012). More research is needed on this topic.
Heroin use during pregnancy can result in neonatal abstinence syndrome (NAS). NAS occurs when heroin passes through the placenta to the fetus during pregnancy, causing the baby to become dependent on opioids. Symptoms include excessive crying, high-pitched cry, irritability, seizures, and gastrointestinal problems, among others (Bandstra et al., 2010).
NAS requires hospitalization of the affected infant and possibly treatment with morphine or methadone to relieve symptoms (Hudak et al., 2012); researchers have also studied buprenorphine for this purpose (Kraft et al., 2011). There is some evidence that buprenorphine is superior to morphine in treating infants with NAS. A NIDA-funded study published in June 2017 found that treating NAS babies with sublingual buprenorphine resulted in a shorter duration of treatment than oral morphine, and also resulted in a shorter length of hospital stay, with similar rates of adverse events (Kraft et al. 2017).
Prescription and Over-the-Counter (OTC) Drugs
Pregnancy can be a confusing time for pregnant women facing many choices about legal drugs, like tobacco and alcohol, as well as prescription and over-the-counter (OTC) drugs that may affect their baby. These are difficult issues for researchers to study because scientists cannot give potentially dangerous drugs to pregnant women. Here are some of the known facts about popular medications and pregnancy:
There are more than 6 million pregnancies in the United States every year, and pregnant women take an average of three to five prescription drugs while pregnant. The U.S. Food and Drug Administration recently issued new rules on drug labeling to provide clearer instructions for pregnant and nursing women, including a summary of the risks of use during pregnancy and breastfeeding, a discussion of the data supporting the summary, and other information to help prescribers make safe decisions (FDA issues final rule, 2014).
Even so, we know little about the effects of taking most medications during pregnancy. This is because pregnant women are often not included in studies to determine safety of new medications before they come on the market (Pregnancy: Medications and Pregnancy, 2014). A recent study shows that use of short-acting prescription opioids such as oxycodone during pregnancy, especially when combined with tobacco and/or certain antidepressant medications, is associated with an increased likelihood of neonatal abstinence syndrome (NAS) in the infant (Patrick et al., 2015).
Although some prescription and OTC medications are safe to take during pregnancy, a pregnant woman should tell her doctor about all prescription medications, OTC cold and pain medicines, and herbal or dietary supplements she is taking or planning to take. This will allow her doctor to weigh the risks and benefits of a medication during pregnancy. In some cases, the doctor may recommend the continued use of specific medications, even though they could have some impact on the fetus. Suddenly stopping the use of a medication may be more risky for both the mother and baby than continuing to use the medication while under a doctor's care (Pregnancy: Medications and Pregnancy, 2014). This could also include medications to treat substance use disorders—something that is discussed in further detail in the "Sex and Gender Differences in Substance Use Disorder Treatment" section.
Some prescription and OTC medications are generally compatible with breastfeeding, and the American Academy of Pediatrics maintains a list of such substances. Others, such as some anti-anxiety and antidepressant medications, have unknown effects (AAP Committee on Drugs, 2001), so mothers who are using these medications should consult with their doctor before breastfeeding. Nursing mothers should contact their infant's health care provider if their infants show any of these reactions to the breast milk: diarrhea, excessive crying, vomiting, skin rashes, loss of appetite, or sleepiness (Ages & Stages, 2014).
Alcohol use while pregnant can result in Fetal Alcohol Spectrum Disorders (FASD), a general term that includes Fetal Alcohol Syndrome, partial Fetal Alcohol Syndrome, alcohol-related disorders of brain development, and alcohol-related birth defects. These effects can last throughout life, causing difficulties with motor coordination, emotional control, schoolwork, socialization, and holding a job. More information can be found on the NIAAA Fetal Alcohol Exposure webpage.
There is currently little research into how a nursing mother's alcohol use might affect her breastfed baby. What science suggests is that, contrary to folklore, alcohol does not increase a nursing mother's milk production, and it may disrupt the breastfed child's sleep cycle (Mennella, n.d.). The American Academy of Pediatrics recommends that alcohol drinking should be minimized during the months a woman nurses and daily intake limited to no more than 2 ounces of liquor, 8 ounces of wine, or two average beers for a 130-pound woman. In this case, nursing should take place at least 2 hours after drinking to allow the alcohol to be reduced or eliminated from the mother's body and milk. This will minimize the amount of alcohol passed to the baby (AAP, 2012).
More information can be found in the NIAAA publication Alcohol's Effect on Lactation.
Nicotine (Tobacco Products and e-Cigarettes)
Almost 16 percent of pregnant women in the United States have smoked in the past month (SAMHSA, 2014). Carbon monoxide and nicotine from tobacco smoke may interfere with the oxygen supply to the fetus. Nicotine also readily crosses the placenta, and concentrations of this drug in the blood of the fetus can be as much as 15 percent higher than in the mother (Wickström, 2007). Smoking during pregnancy increases the risk for certain birth defects, premature birth, miscarriage, and low birth weight (Reproductive Health, 2014) and is estimated to have caused 1,015 infant deaths annually from 2005 through 2009 (CDC, 2014). Newborns of smoking mothers also show signs of stress and drug withdrawal consistent with what has been reported in infants exposed to other drugs. In some cases, smoking during pregnancy may be associated with sudden infant death syndrome (SIDS), as well as learning and behavioral problems and an increased risk of obesity in children. In addition, smoking more than one pack a day during pregnancy nearly doubles the risk that the affected child will become addicted to tobacco if that child starts smoking (Rydell et al., 2014). Even a mother's secondhand exposure to cigarette smoke can cause problems; such exposure is associated with premature birth and low birth weight, for example (Khader et al., 2011). The U.S. Department of Health and Human Services provides resources specifically designed to help pregnant women quit smoking.
Recent research provides strong support that nicotine is a gateway drug, making the brain more sensitive to the effects of other drugs such as cocaine (NIH study examines nicotine, 2011). This shows that pregnant women who use nicotine may be affecting their baby's brain in ways they may not anticipate. Because e-cigarettes typically also contain nicotine, those products may also pose a risk to the baby's health. More research is needed.
Similar to pregnant women, nursing mothers are also advised against using tobacco. New mothers who smoke should be aware that nicotine is passed through breast milk (Mennella et al., 2007), so tobacco use can impact the infant's brain and body development—even if the mother never smokes near the baby. There is also evidence that the milk of mothers who smoke smells and may taste like cigarettes. It is unclear whether this will make it more likely that exposed children may find tobacco flavors/smells more appealing later in life (Mennella & Beauchamp, 1998).
Newborns exposed to secondhand smoke are at greater risk for SIDS, respiratory illnesses (asthma, respiratory infections, and bronchitis), ear infections (Smoking & Tobacco Use, 2015), cavities (Aligne et al., 2003), and increased medical visits and hospitalizations (Leung et al., 2004). If a woman smokes and is planning a pregnancy, the ideal time to seek smoking cessation help is before she becomes pregnant.
- Ages & Stages: Medications and Breastfeeding. HealthyChildren.org. American Academy of Pediatrics. www.healthychildren.org/English/ages-stages/baby/breastfeeding/Pages/Medications-and-Breastfeeding.aspx. Updated November 3, 2014. Accessed July 7, 2015.
- Aligne CA, Moss ME, Auinger P, Weitzman M. Association of pediatric dental caries with passive smoking. JAMA. 2003;289(10):1258-1264.
- American Academy of Pediatrics (AAP) Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108(3):776-789.
- American Academy of Pediatrics (AAP). Policy statement: breastfeeding and the use of human milk. Pediatrics. 2012;129(3):e827-e841.
- American College of Obstetricians and Gynecologists (ACOG). Marijuana use during pregnancy and lactation. Committee Opinion No. 637. Obstet Gynecol. 2015;126:234-238.
- Antonelli T, Tomasini MC, Tattoli M, et al. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex. 2005;15(12):2013-2020.
- Asch RH, Smith CG. Effects of delta 9-THC, the principal psychoactive component of marijuana, during pregnancy in the rhesus monkey. J Reprod Med. 1986;31(12):1071-1081.
- Astley SJ, Little RE. Maternal marijuana use during lactation and infant development at one year. Neurotoxicol Teratol. 1990;12(2):161-168.
- Bandstra ES, Morrow CE, Mansoor E, Accornero VH. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis. 2010;29(2):245-258.
- Bauer CR, Langer JC, Shankaran S, et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med. 2005;159(9):824-834.
- Cain MA, Bornick P, Whiteman V. The maternal, fetal, and neonatal effects of cocaine exposure in pregnancy. Clin Obstet Gynecol. 2013;56(1):124-132.
- Campolongo P, Trezza V, Ratano P, Palmery M. Cuomo V. Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl). 2011;214(1):5-15.
- Centers for Disease Control and Prevention (CDC). The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
- Chasnoff IJ, Bussey ME, Savich R, Stack CM. Perinatal cerebral infarction and maternal cocaine use. J Pediatr. 1986;108(3):456-459.
- de Moraes Barros MC, Guinsburg R, Mitsuhiro S, Chalem E, Laranjeira RR. Neurobehavioral profile of healthy full-term newborn infants of adolescent mothers. Early Hum Dev. 2008;84(5):281-287.
- Diaz SD, Smith LM, LaGasse LL, et al. Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age. J Pediatr. 2014;164(6):1333-1338.
- Djulus J, Moretti M, Koren G. Marijuana use and breastfeeding. Can Fam Physician. 2005;51(3):349-350.
- Eyler FD, Behnke M, Garvan CW, Woods NS, Wobie K, Conlon M. Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure. Neurotoxicol Teratol. 2001;23(5):399-411.
- FDA issues final rule on changes to pregnancy and lactation labeling information for prescription drug and biological products [press release]. Silver Spring, MD: U.S. Food and Drug Administration; December 3, 2014. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm425317.htm. Accessed July 7, 2015.
- Fried PA, Makin JE. Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population. Neurotoxicol Teratol. 1987;9(1):1-7.
- Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol. 2001;23(1):1-11.
- Fried PA, Watkinson B, Gray R. A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol. Neurotoxicol Teratol. 1992;14(5):299-311.
- Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol. 2000;22(3):325-336.
- Gorman MC, Orme KS, Nguyen NT, Kent EJ 3rd, Caughey AB. Outcomes in pregnancies complicated by methamphetamine use. Am J Obstet Gynecol. 2014;211(4):429.e1-e7.
- Hayatbakhsh MR, Flenady VJ, Gibbons KS, et al. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res. 2012;71(2):215-219.
- Hudak ML, Tan RC, The Committee on Drugs, The Committee on Fetus and Newborn. Clinical report: neonatal drug withdrawal. Pediatrics. 2012;129(2):e540-e560.
- Janisse JJ, Bailey BA, Ager J, Sokol RJ. Alcohol, tobacco, cocaine, and marijuana use: relative contributions to preterm delivery and fetal growth restriction. Subst Abus. 2014;35(1):60-67.
- Khader YS, Al-Akour N, Alzubi IM, Lataifeh I. The association between second hand smoke and low birth weight and preterm delivery. Matern Child Health J. 2011;15(4):453-459.
- Kline J, Hutzler M, Levin B, Stein Z, Susser M, Warburton D. Marijuana and spontaneous abortion of known karyotype. Paediatr Perinat Epidemiol. 1991;5(3):320-332.
- Kraft WK, Dysart K, Greenspan JS, Gibson E, Kaltenbach K, Ehrlich ME. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction. 2011;106(3):574-580.
- LaGasse LL, Derauf C, Smith LM, et al. Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics. 2012;129(4):681-688.
- Leung GM, Ho LM, Lam TH. Secondhand smoke exposure, smoking hygiene, and hospitalization in the first 18 months of life. Arch Pediatr Adolesc Med. 2004;158(7):687-693.
- Mark K, Desai A, Terplan M. Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes [published online ahead of print April 19, 2015]. Arch Womens Ment Health.
- Martin CE, Longinaker N, Mark K, Chisolm, MS, Terplan M. Recent trends in treatment admissions for marijuana use during pregnancy. J Addict Med. 2015;9(2):99-104.
- Mennella JA, Beauchamp GK. Smoking and the flavor of breast milk. N Engl J Med. 1998;339(21):1559-1560.
- Mennella J. Alcohol's Effect on Lactation. National Institute on Alcohol Abuse and Alcoholism. http://pubs.niaaa.nih.gov/publications/arh25-3/230-234.htm. Accessed July 7, 2015.
- Mennella JA, Yourshaw LM, Morgan LK. Breastfeeding and smoking: short-term effects on infant feeding and sleep. Pediatrics. 2007;120(3):497-502.
- Mereu G, Fà M, Ferraro L, et al. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci U S A. 2003;100(8):4915-4920.
- Neonatal abstinence syndrome. MedlinePlus. U.S. National Library of Medicine. https://medlineplus.gov/ency/article/007313.htm. Updated January 31, 2014. Accessed July 7, 2015.
- NIH study examines nicotine as a gateway drug [news release]. Rockville, MD: National Institute on Drug Abuse; November 2, 2011. www.drugabuse.gov/news-events/news-releases/2011/11/nih-study-examines-nicotine-gateway-drug. Accessed July 7, 2015.
- Patrick SW, Dudley J, Martin PR, et al. Prescription opioid epidemic and infant outcomes. Pediatrics. 2015;135(5):842-850.
- Perez-Reyes M, Wall ME. Presence of Δ9-tetrahydrocannabinol in human milk. N Engl J Med. 1982;307(13):819-820.
- Pregnancy: Medications and Pregnancy. Centers for Disease Control and Prevention. www.cdc.gov/pregnancy/meds/index.html. Reviewed December 3, 2014. Accessed July 7, 2015.
- Reproductive Health: Tobacco Use and Pregnancy. Centers for Disease Control and Prevention. www.cdc.gov/Reproductivehealth/TobaccoUsePregnancy/index.htm. Reviewed August 5, 2014. Accessed July 7, 2015.
- Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt L. Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol. 2002;24(3):309-320.
- Roberson EK, Patrick WK, Hurwitz EL. Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai'i. Hawaii J Med Public Health. 2014;73(9):283-287.
- Rydell M, Magnusson C, Cnattingius S, Granath F, Svensson AC, Galanti MR. Exposure to maternal smoking during pregnancy as a risk factor for tobacco use in adult offspring. Am J Epidemiol. 2014;179(12):1409-1417.
- Schaefer TL, Grace CE, Braun AA, et al. Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA. Int J Neuropsychopharmacol. 2013;16(6):1383-1394.
- Schempf AH, Strobino DM. Illicit drug use and adverse birth outcomes: is it drugs or context? J Urban Health. 2008;85(6):858-873.
- Shiono PH, Klebanoff MA, Nugent RP, et al. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol. 1995;172(1 Pt 1):19-27.
- Singer LT, Moore DG, Min MO, et al. One-year outcomes of prenatal exposure to MDMA and other recreational drugs. Pediatrics. 2012;130(3):407-413.
- Smith LM, LaGasse LL, Derauf C, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics. 2006;118(3):1149-1156.
- Smoking & Tobacco Use: Secondhand Smoke (SHS) Facts. Centers for Disease Control and Prevention. www.cdc.gov/tobacco/data_statistics/fact_sheets/secondhand_smoke/general_facts/index.htm#harm. Reviewed February 6, 2015. Accessed July 7, 2015.
- Sonon KE, Richardson GA, Cornelius JR, Kim KH, Day NL. Prenatal marijuana exposure predicts marijuana use in young adulthood. Neurotoxicol Teratol. 2015;47:10-15.
- Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. HHS Publication No. (SMA) 14-4863. NSDUH Series H-48.
- Tobacco, drug use in pregnancy can double risk of stillbirth. NIH network study documents elevated risk associated with marijuana, other substances [news release]. Bethesda, MD: Eunice Kennedy Shriver National Institute of Child Health and Human Development; December 11, 2013. www.nichd.nih.gov/news/releases/Pages/121113-stillbirth-drug-use.aspx. Accessed July 7, 2015.
- Trezza V. Campolongo P, Cassano T, et al. Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psychopharmacology (Berl). 2008;198(4):529-537.
- Wendell AD. Overview and epidemiology of substance abuse in pregnancy. Clin Obstet Gynecol. 2013;56(1):91-96.
- Westfall RE, Janssen PA, Lucas P, Capler R. Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness.' Complement Ther Clin Pract. 2006;12(1):27-33.
- Wickström R. Effects of nicotine during pregnancy: human and experimental evidence. Curr Neuropharmacol. 2007;5(3):213-222.
- Wilcox AJ, Weinberg CR, Baird DD. Risk factors for early pregnancy loss. Epidemiology. 1990;1(5):382-385.
Cite this article
NIDA. (2016, September 20). Substance Use in Women. Retrieved from https://www.drugabuse.gov/publications/research-reports/substance-use-in-women
This series of reports simplifies the science of research findings for the educated lay public, legislators, educational groups, and practitioners. The series reports on research findings of national interest.